Mycoplasma pneumoniae DNA detection and specific antibody class response in patients from two tertiary care hospitals in tropical Sri Lanka
Author(s) -
Lakmini Inoka Wijesooriya,
Tuckweng Kok,
Jennifer Perera,
Y. Tilakarathne,
N.P. Sunil-Chandra
Publication year - 2018
Publication title -
journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000813
Subject(s) - mycoplasma pneumoniae , pneumonia , medicine , pharyngitis , bronchitis , immunology , mycoplasma pneumonia , respiratory tract infections , atypical pneumonia , serology , moraxella catarrhalis , antibody , immunoglobulin m , immunoglobulin g , streptococcus pneumoniae , microbiology and biotechnology , respiratory system , biology , antibiotics
Respiratory tract infections are a major cause of global morbidity and mortality. Pneumonia is the ninth leading cause of mortality in Sri Lanka. Atypical pathogens cause about one-fifth of community-acquired pneumonia, while Mycoplasma pneumoniae accounts for about 50 %. This study aimed to determine the seroprevalence of M. pneumoniae respiratory tract infections in Sri Lanka while attempting to understand the relationships between the serology and PCR.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom